$NGEN

Leerink Partners Initiates Coverage on NervGen Pharma With Outperform Rating, $10 Price Target

TD Cowen Initiates NervGen Pharma at Buy

NervGen Pharma (NGEN) has an average rating of buy and mean price target of $10.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

HC Wainwright Initiates Coverage on NervGen Pharma With Buy Rating, $18 Price Target

NervGen Pharma Corp. (NGEN) has an average rating of Buy and mean price target of $10.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)